WEEK 1 - CINEMATIC ULTRA-HIGH-YIELD RESPIRATORY MEDICINE

EMBRYOLOGY, ARCHITECTURE, & THE MECHANICS OF BREATHING

---

"Before you can understand disease, you must understand how the lung was built, how it breathes, and how it talks to the blood."

---

DAY 1

LUNG EMBRYOLOGY, CONGENITAL ANOMALIES & TRACHEOESOPHAGEAL FISTULAS

---

1. BIG PICTURE OVERVIEW

---

2. CINEMATIC VISUALIZATION - THE LUNG'S BIRTH

Imagine a single tube - the primitive foregut - running down the neck of a 3-week embryo. From its front wall, a tiny bud pushes outward, like a finger pressing through wet clay. This is the respiratory diverticulum. It is the entire future lung.

Over the next weeks, this bud branches again and again - 23 generations of branching - like a tree growing in fast-forward. The airways push into surrounding mesenchyme. Two tissue partners - endoderm (lining) and mesoderm (muscle, cartilage, vessels) - must coordinate every step. A miss in this molecular conversation creates a congenital anomaly.

Meanwhile, the original single tube is being partitioned by two ridges - the tracheoesophageal folds - growing toward each other like two hands closing. If they fail to meet completely, a fistula remains.

---

3. DEVELOPMENTAL TIMELINE - THE FIVE STAGES

Exam Trap: A baby born at 24 weeks is at the canalicular-saccular boundary. They have just enough alveolar-capillary interface to survive with maximal support, but no surfactant yet. This explains why RDS peaks at 28-32 weeks.

---

4. PATHOPHYSIOLOGY FLOWCHAIN - LUNG BUD FORMATION

FOREGUT (single endodermal tube)
           ↓
    Week 4: Respiratory diverticulum buds from ventral wall
           ↓
    Tracheoesophageal folds grow laterally → fuse in midline
           ↓
    Trachea (ventral) separated from Esophagus (dorsal)
           ↓
    Lung bud → Right (3 lobes) + Left (2 lobes) bronchial buds
           ↓
    23 generations of dichotomous branching
           ↓
    Endoderm = epithelium of airways
    Mesoderm = cartilage, smooth muscle, vessels, connective tissue
           ↓
    FAILURE AT ANY STEP = Specific congenital anomaly

---

5. CONGENITAL ANOMALIES - CLASSIFIED BY STAGE

A. TEF & Esophageal Atresia (EA)

---

THE 5 TYPES OF TEF - VISUAL MAP

TYPE A (Pure EA, no fistula) - 7%
   ESOPHAGUS: [blind upper pouch] .... [blind lower pouch]
   TRACHEA:   intact, no connection
   Clinical: gasless abdomen on X-ray (no air reaching gut)

TYPE B - 1%
   ESOPHAGUS: [upper pouch CONNECTED to trachea] ..... [blind lower pouch]
   TRACHEA:   fistula proximally
   
TYPE C - THE BIG ONE - 88%
   ESOPHAGUS: [blind upper pouch] ..... [lower pouch CONNECTED to trachea]
   TRACHEA:   distal fistula
   Clinical: AIR goes into stomach → abdominal distension
             GASTRIC ACID goes into trachea → chemical pneumonitis

TYPE D - 2%
   ESOPHAGUS: [both ends connected to trachea]
   Worst type

TYPE E (H-type, no atresia) - 3%
   ESOPHAGUS: intact (no atresia)
   TRACHEA:   fistula connecting mid-esophagus to trachea
   Clinical: Subtle! Recurrent aspiration pneumonia, choking with feeds
             Diagnosed with barium swallow or bronchoscopy

Exam Trap: TYPE C is 88% of all cases. If the MCQ says "most common TEF" - it's Type C (EA + distal fistula). The gas travels DOWN the fistula into the stomach. The gastric acid travels UP the fistula into the trachea.

---

CLINICAL PRESENTATION OF TEF (TYPE C)

NEWBORN → Excessive drooling, frothing at mouth
              ↓
         Attempt to feed → immediate choking + cyanosis
              ↓
         Air passes down fistula → abdominal distension
              ↓
         Stomach acid refluxes UP fistula → chemical pneumonitis
              ↓
         Atelectasis → respiratory failure
              ↓
         NGT passed → coils in blind esophageal pouch (fails to reach stomach)
              ↓
         X-ray: NGT coiled in neck/chest + GAS in stomach (distal fistula)

• Choking - with first feed
• Cyanosis - from aspiration/pneumonitis
• Coiling of NGT - fails to reach stomach

---

ASSOCIATED ANOMALIES - VACTERL

Mnemonic: "Very Awkward Confusing TEaching, Remember Later"

---

INVESTIGATIONS FOR TEF

---

TREATMENT LOGIC

IMMEDIATE:
  Nurse head-up (30°) + Replogle tube (continuous suction of upper pouch)
  → Prevents aspiration of pooled secretions
  
SURGICAL:
  Thoracotomy (right posterolateral)
  → Divide fistula
  → End-to-end esophageal anastomosis
  
WHY TIMING MATTERS:
  Premature/small baby → staged repair (gastrostomy first, anastomosis later)
  Mature stable baby → primary repair
  
POST-OP RISKS:
  Anastomotic leak → stricture → dysphagia long-term
  Recurrent fistula
  Tracheomalacia (floppy trachea - the cartilage was disrupted)
  GERD (very common - lower esophageal anatomy disrupted)

---

B. Other Congenital Lung Anomalies

---

6. MEMORY ANCHORS

Every Proud Canadian Sings Aloud

• Embryonic (4-7w)
• Pseudoglandular (5-17w)
• Canalicular (16-26w)
• Saccular (24-38w)
• Alveolar (36w - 3yrs)

---

7. EXAM PEARLS - DAY 1

• Most common TEF type: C (88%) - EA + DISTAL fistula
• Type with no gas on AXR: A (pure EA, no distal communication)
• H-type (E) trap: Normal feeding initially → recurrent aspiration pneumonia as child grows
• Polyhydramnios in utero: Think EA - fetus cannot swallow
• Sequestration blood supply: SYSTEMIC artery (aortic branch) - that's the diagnostic key
• Tracheomalacia post-TEF repair = most common post-operative airway complication

---

---

DAY 2

HISTOLOGICAL ZONING: CONDUCTING VS. RESPIRATORY ZONES & CELLULAR CLEANSING MECHANISMS

---

1. BIG PICTURE OVERVIEW

---

2. CINEMATIC VISUALIZATION

Picture the airways as a city transit system. The trachea is the main highway - large, rigid, cartilage-reinforced. It splits at the carina into two interstate roads (main bronchi). These split again and again, getting smaller and losing their cartilage - becoming more flexible, more muscular. By the time you reach the terminal bronchiole (generation 16), you're on a tiny capillary road. Then suddenly, the walls become thin, perforated, gossamer - you have arrived at the respiratory zone. Here, oxygen diffuses across membranes so thin (0.5 micrometers) they are nearly theoretical constructs.

---

3. THE ZONES - ARCHITECTURAL MAP

TRACHEA (Generation 0)
    ↓
MAIN BRONCHI (Gen 1)
    ↓
LOBAR BRONCHI (Gen 2)       ┐
    ↓                        │
SEGMENTAL BRONCHI (Gen 3)   │  CONDUCTING ZONE
    ↓                        │  (Generations 0-16)
SUBSEGMENTAL BRONCHI        │  = ANATOMICAL DEAD SPACE
    ↓                        │  = ~150 mL in adults
BRONCHIOLES (Gen 4-11)      │  = NO GAS EXCHANGE
    ↓                        │
TERMINAL BRONCHIOLES (16)   ┘
    ↓
RESPIRATORY BRONCHIOLES (17-19) ┐
    ↓                            │  RESPIRATORY ZONE
ALVEOLAR DUCTS (20-22)          │  (Gen 17-23)
    ↓                            │  = Gas exchange begins
ALVEOLAR SACS (23)              │  = ~300 million alveoli
ALVEOLI                         ┘  = Surface area ~70-80 m²

---

4. CELLULAR ATLAS - WHO LIVES WHERE

CONDUCTING ZONE CELLS

RESPIRATORY ZONE CELLS

Exam Trap: Type II pneumocytes are the SURVIVORS of alveolar injury. They proliferate after damage and can regenerate Type I cells. In diffuse alveolar damage (ARDS), you see Type II pneumocyte hyperplasia lining the damaged alveolar walls.

---

5. THE MUCOCILIARY ESCALATOR - THE LUNG'S CLEANING SYSTEM

INHALED PARTICLE/PATHOGEN lands in airway
              ↓
Trapped in MUCUS layer (gel layer on top of periciliary sol layer)
              ↓
Cilia beat at 1000 strokes/min in coordinated metachronal waves
              ↓
Mucus transported UPWARD (toward larynx) at 1-2 cm/min
              ↓
Reaches larynx → SWALLOWED or EXPECTORATED
              ↓
NORMAL LUNG: Lungs protected from most inhaled particles

When the Escalator Fails:

---

6. THE TWO-LAYER MUCUS MODEL

AIRWAY LUMEN
    │
    ├── GEL LAYER (thick, viscoelastic) ← Particles trapped here
    │        ↑
    │    Cilia tips push this layer
    │        
    ├── SOL LAYER (periciliary fluid, aqueous) ← Cilia beat here freely
    │
EPITHELIUM (ciliated cells)

---

7. ALVEOLAR MACROPHAGE - THE SILENT GUARDIAN

PARTICLE enters alveolus
              ↓
Alveolar macrophage ENGULFS particle
              ↓
Can be:
  → Degraded intracellularly
  → Transported to mucociliary escalator (coughed up)
  → Transported to lymphatics
  → UNABLE TO DEGRADE (silica, asbestos) → remains in lung
              ↓
FRUSTRATED PHAGOCYTOSIS:
  Macrophage releases proteases, ROS, cytokines
              ↓
  INFLAMMATION + FIBROSIS (pneumoconiosis)

---

8. MEMORY ANCHORS - DAY 2

• Dead Space = No exchange
• Alveoli = Where life happens

• Squamous cell Ca → Basal cells (bronchi)
• Adenocarcinoma → Club (Clara) cells (bronchioles) / Type II
• Small cell Ca → Kulchitsky (neuroendocrine) cells
• Large cell → undifferentiated

---

9. EXAM PEARLS - DAY 2

• Anatomical dead space = ~150 mL = conducting zone volume
• Total lung capacity needed to calculate alveolar ventilation: VA = (VT - VD) x RR
• Goblet cells extend to bronchi - NOT into bronchioles (where Club cells replace them)
• Kartagener's = bronchiectasis + situs inversus + infertility (dynein arm mutation)
• Type II pneumocytes survive lung injury and regenerate the alveolar surface
• Lamellar bodies in Type II pneumocytes = surfactant storage (seen on EM)

---

---

DAY 3

VENTILATORY MECHANICS: PRESSURES, COMPLIANCE, ELASTANCE & SURFACTANT PHYSICS

---

1. BIG PICTURE OVERVIEW

---

2. CINEMATIC VISUALIZATION

Imagine holding a tennis ball in one hand and a squeezed spring in the other. The tennis ball wants to stay compressed (lung elastic recoil). The spring wants to expand (chest wall recoil). Now attach them together through a thin fluid layer (the pleural space). At rest, they reach equilibrium - neither fully expanded nor collapsed. This equilibrium point is FRC.

Now imagine the surfactant as a molecular detergent lining the inside of a tiny balloon (alveolus). Without it, the inside surface pulls so hard that the balloon collapses. With it, the surface tension drops to nearly zero at small volumes, keeping the balloon open even at end-expiration.

---

3. THE PRESSURE FRAMEWORK

Key Pressures to Know

The Breathing Mechanics Chain:

INSPIRATION:
  Diaphragm contracts → thorax expands
       ↓
  Pleural pressure drops (more negative: -5 → -8 cmH2O)
       ↓
  Transpulmonary pressure increases
       ↓
  Alveoli expand (follow chest wall)
       ↓
  Alveolar pressure drops BELOW atmospheric
       ↓
  AIR FLOWS IN (down pressure gradient)

EXPIRATION (at rest - PASSIVE):
  Diaphragm relaxes → chest recoils inward
       ↓
  Pleural pressure rises toward -5 cmH2O
       ↓
  Alveolar pressure rises ABOVE atmospheric
       ↓
  AIR FLOWS OUT

Exam Trap: Normal quiet expiration is PASSIVE (no muscle contraction). Only forced expiration uses muscles (internal intercostals, abdominals). This is why patients with neuromuscular disease cannot breathe - their inspiratory muscles are weak.

---

4. COMPLIANCE & ELASTANCE

The Fundamental Relationship

EMPHYSEMA:
  Elastin destruction → lung is floppy
  ↓
  HIGH compliance (easy to inflate)
  ↓
  Loses elastic recoil to push air OUT
  ↓
  Air trapping → hyperinflation → barrel chest

FIBROSIS:
  Collagen deposition → lung is stiff
  ↓
  LOW compliance (hard to inflate)
  ↓
  Patient takes small, rapid breaths (tachypnea)
  ↓
  Reduced TLC, reduced FRC

Normal Compliance Values

• Lung compliance alone: ~200 mL/cm H2O
• Chest wall compliance alone: ~200 mL/cm H2O
• Combined (lungs + chest wall): ~100 mL/cm H2O

---

5. SURFACTANT PHYSICS - DEEP DIVE

What is Surfactant?

• 80% Phospholipids (DPPC - dipalmitoylphosphatidylcholine is the main surface-active component)
• 10% Other lipids
• 10% Proteins (SP-A, SP-B, SP-C, SP-D)

• SP-B and SP-C: hydrophobic, essential for surface activity and adsorption
• SP-A and SP-D: hydrophilic collectins, involved in innate immunity (not surface activity) (Murray & Nadel's Textbook of Respiratory Medicine)

---

The Physics: LaPlace's Law

For a sphere (alveolus):
                2T
Pressure (P) = ────
                 r

Where T = surface tension, r = radius

WITHOUT surfactant:
  T is constant
  Small alveoli (small r) → HIGH pressure inside
  Large alveoli (large r) → LOW pressure inside
  Air flows from HIGH to LOW pressure
  → Small alveoli empty into large alveoli → ATELECTASIS

WITH surfactant:
  T DECREASES as alveolus shrinks (area decreases → DPPC packs more tightly)
  Small alveoli: T↓↓ → P normalizes
  Large alveoli: T slightly higher but r is large → P also normalizes
  → Equal pressures → STABLE alveoli of different sizes coexist

---

Surfactant Functions Summary

1. REDUCES SURFACE TENSION
   → Reduces work of breathing
   → Prevents alveolar collapse at end-expiration

2. MAINTAINS ALVEOLAR STABILITY (LaPlace equation)
   → Prevents small alveoli emptying into large ones

3. PREVENTS PULMONARY EDEMA
   → Lower surface tension = less "pulling" force that draws fluid into alveoli
   → (Starling forces: reduced surface tension prevents transudation)

4. INNATE IMMUNITY (SP-A, SP-D)
   → Opsonization of bacteria and viruses
   → Complement activation

---

Surfactant Cycle

Type II Pneumocyte
    ↓ synthesis (DPPC from glucose + choline)
Lamellar bodies (storage organelles inside Type II cells)
    ↓ exocytosis
Tubular myelin (intermediate extracellular form)
    ↓ adsorption
Air-liquid interface monolayer (active surfactant)
    ↓ cycling with breathing
Degraded / Recycled by Type II cells (~90% recycled)

---

Clinical Surfactant Disorders

---

6. LUNG VOLUMES - THE ARCHITECTURAL BLUEPRINT

TLC (Total Lung Capacity) = ~6L (all air the lung can hold)
  │
  ├── VC (Vital Capacity) = ~4.8L (TLC - RV)
  │    │
  │    ├── IRV (Inspiratory Reserve Vol) = ~3L (above TV)
  │    ├── TV (Tidal Volume) = ~0.5L (resting breath)
  │    └── ERV (Expiratory Reserve Vol) = ~1.3L (below TV)
  │
  └── RV (Residual Volume) = ~1.2L (cannot be exhaled)
  
FRC (Functional Residual Capacity) = ERV + RV = ~2.5L
  = The resting lung volume where lung recoil = chest wall recoil

Exam Trap: Spirometry CANNOT measure RV, FRC, or TLC directly. You need body plethysmography or helium dilution. This is why spirometry can diagnose obstruction and restriction but body plethysmography is needed to confirm TLC.

---

7. MEMORY ANCHORS - DAY 3

"Compliant = Collapsible (floppy)" - Emphysema "Elastance = Effort needed" - Fibrosis

"Small alveoli without surfactant → HIGH pressure → collapse into big ones" Surfactant "saves the small ones" by reducing T proportionally

---

8. EXAM PEARLS - DAY 3

• Normal FRC = ~2.5L; In emphysema FRC increases (air trapping); In fibrosis FRC decreases
• Surfactant is predominantly DPPC (dipalmitoylphosphatidylcholine)
• SP-B and SP-C = surface activity; SP-A and SP-D = immune function
• Antenatal steroids accelerate lung maturity by inducing surfactant synthesis in Type II cells
• Compliance increases with age (lung connective tissue becomes lax) - but this is pathological in emphysema
• LaPlace equation: P = 2T/r. Surfactant reduces T as r decreases.

---

---

DAY 4

SPIROMETRY: DYNAMIC FLOW-VOLUME LOOPS - OBSTRUCTIVE vs RESTRICTIVE

---

1. BIG PICTURE OVERVIEW

• Normal: FEV1/FVC ≥ 0.70 (70%)
• Obstruction: FEV1/FVC < 0.70
• Restriction: FEV1/FVC normal or increased, but FVC reduced

---

2. THE KEY SPIROMETRIC MEASUREMENTS

---

3. THE FLOW-VOLUME LOOP - READING IT CINEMATICALLY

NORMAL FLOW-VOLUME LOOP:

       EXPIRATION (flows upward from RV to TLC)
            ↑ Peak Flow (sharp rise to peak)
            │╲
            │  ╲  
FLOW        │    ╲ (gradual linear descent)
(L/s)       │      ╲
            │        ╲_______________
    TLC ────────────────────────────── RV
            ← VOLUME →

INSPIRATION (flows downward)
            ───────────────────────────
           ╱                           ╲
          ╱  (smooth, symmetric curve)  ╲
         ╱_______________________________╲

Obstructive Pattern

OBSTRUCTIVE (COPD, Asthma):

        ↑ 
FLOW    │ /╲ 
(L/s)   │/   ╲_________
        │             ╲
        │               ╲___
    TLC ─────────────────────── RV
        (TLC increased;       (RV increased)
         FVC may be normal     due to air trapping)

KEY FEATURES:
  - FEV1 ↓↓↓
  - FVC: normal or slightly ↓
  - FEV1/FVC < 0.70 ← DIAGNOSTIC
  - Scooped-out (concave) expiratory limb ← PATHOGNOMONIC
  - RV increases (air trapping)
  - TLC increases (hyperinflation)

Restrictive Pattern

RESTRICTIVE (Fibrosis, Neuromuscular):

        ↑ 
FLOW    │  /╲ 
(L/s)   │ /   ╲
        │/     ╲
        │────────╲──
    TLC ─────────── RV
        (NARROW loop - everything reduced)

KEY FEATURES:
  - FEV1 ↓ (because FVC is small)
  - FVC ↓↓↓ ← REDUCED
  - FEV1/FVC: NORMAL or ↑ (both fall proportionately, ratio preserved)
  - Loop is narrow and tall (proportional reduction)
  - RV normal or reduced
  - TLC ↓ ← Confirms restriction (needs plethysmography)

---

4. THE MASTER COMPARISON TABLE

---

5. DIFFUSION CAPACITY (DLCO) - THE FORGOTTEN TEST

Exam Trap - COPD distinction: Chronic bronchitis has NORMAL DLCO (mucosal disease). Emphysema has LOW DLCO (alveolar destruction). This is how spirometry + DLCO differentiates them.

---

6. SEVERITY GRADING OF OBSTRUCTION (GOLD CRITERIA)

---

7. REVERSIBILITY TESTING

---

8. FLOW-VOLUME LOOPS - UPPER AIRWAY LESIONS

FIXED UPPER AIRWAY OBSTRUCTION (e.g., tracheal stenosis):
  → Both inspiratory AND expiratory limbs flattened = "PLATEAU"
  (Flow limited equally in both directions)

VARIABLE EXTRATHORACIC OBSTRUCTION (e.g., vocal cord lesion):
  → Inspiratory limb flattened only
  (During inspiration, negative pressure collapses extrathoracic airway)
  → During expiration, positive pressure OPENS it

VARIABLE INTRATHORACIC OBSTRUCTION (e.g., tracheomalacia):
  → Expiratory limb flattened only
  (During forced expiration, positive pleural pressure compresses trachea)
  → During inspiration, negative pressure OPENS it

---

9. MEMORY ANCHORS - DAY 4

• Think "SCOOP of ice cream scooped out of expiratory limb"

• Think "NARROW road - everything proportionately squeezed"

---

10. EXAM PEARLS - DAY 4

• FEV1/FVC < 0.70 = obstruction (not negotiable)
• FVC reduced + normal ratio = restriction (confirm with TLC by plethysmography)
• Scooped expiratory limb = small airway obstruction
• Post-bronchodilator spirometry is the gold standard for COPD diagnosis
• DLCO normal in asthma and chronic bronchitis; low in emphysema and fibrosis
• Fixed bilateral plateau on loop = tracheal stenosis (emergency recognition)

---

---

DAY 5

ALVEOLAR GAS EQUATION, V/Q MISMATCH & SHUNTS

---

1. BIG PICTURE OVERVIEW

---

2. CINEMATIC VISUALIZATION

Picture the lung as a high-rise apartment building. The penthouse (lung apex) gets plenty of air flow - the elevator (ventilation) works well. But the penthouse is on the top floor, far from the boiler room (heart) - so heating (blood flow/perfusion) is poor. The basement (lung base) is poorly ventilated (gravity pulls it closed) but heavily perfused (gravity pulls blood down). The result: NO floor in the building has a perfect heating-to-ventilation ratio.

Now add a blood clot (PE) to one floor's plumbing - ventilation continues, but perfusion stops. That floor becomes dead space. Or add pneumonia to another floor - perfusion continues, but ventilation stops. That floor becomes a shunt. Both scenarios starve the blood of oxygen.

---

3. THE ALVEOLAR GAS EQUATION

PAO2 = FiO2 × (Patm - PH2O) - (PaCO2/RQ)

Where:
  PAO2   = Alveolar PO2 (what the alveolus CAN offer)
  FiO2   = Fraction of inspired O2 (0.21 at room air)
  Patm   = 760 mmHg
  PH2O   = Water vapor pressure = 47 mmHg
  PaCO2  = Arterial CO2 (reflects alveolar CO2)
  RQ     = Respiratory Quotient = 0.8 (CO2 produced / O2 consumed)

At room air, normal conditions:
  PAO2 = 0.21 × (760 - 47) - (40/0.8)
       = 0.21 × 713 - 50
       = 149.7 - 50
       = ~100 mmHg

A-a gradient = PAO2 - PaO2

Normal A-a gradient: < 10-15 mmHg (young adult)
                     Increases with age: use Age/4 + 4 as rough guide

NORMAL A-a gradient → Problem is OUTSIDE the alveolus
  (e.g., hypoventilation, breathing low O2 - altitude)

ELEVATED A-a gradient → Problem is at or beyond the alveolus
  (V/Q mismatch, diffusion defect, shunt)

---

4. THE 5 CAUSES OF HYPOXEMIA - MASTER TABLE

Exam Trap: The shunt is the ONLY cause of hypoxemia that does NOT correct with 100% O2. This is the test that proves shunt physiology. Even breathing pure O2 cannot oxygenate blood that never contacts alveoli.

---

5. V/Q MISMATCH - THE SPECTRUM

PERFECT V/Q = 1.0 (ideal matching)

Dead Space (V/Q = ∞):
  Ventilation present → Perfusion absent
  CAUSE: Pulmonary embolism, bullae
  EFFECT: Wasted ventilation; CO2 rises (dead space gas)
  RESULT: ↑ PaCO2 + ↓ PaO2 (patient hyperventilates to compensate)

Shunt (V/Q = 0):
  Perfusion present → Ventilation absent
  CAUSE: Pneumonia (consolidated alveoli), atelectasis, ARDS
  EFFECT: Deoxygenated blood mixes with oxygenated blood
  RESULT: ↓ PaO2 (refractory hypoxemia - does NOT correct with O2)

NORMAL LUNG V/Q VARIATION:
  Apex V/Q ≈ 3 (over-ventilated, under-perfused)
  Base V/Q ≈ 0.6 (under-ventilated, over-perfused)
  Average V/Q = 0.8 ← normal

---

6. GRAVITY AND REGIONAL V/Q DIFFERENCES

APEX (Zone 1):
  - Ventilation: moderate
  - Perfusion: LOW (gravity pulls blood away)
  - V/Q: HIGH (~3)
  - PO2 highest, PCO2 lowest
  - Preferred zone for TB (high O2 = good for Mycobacterium)

BASE (Zone 3):
  - Ventilation: moderate
  - Perfusion: HIGH (gravity pools blood here)
  - V/Q: LOW (~0.6)
  - PO2 lowest, PCO2 highest
  - Most pulmonary edema accumulates here
  - Most dependent pneumonia here

WEST'S ZONES:
  Zone 1 (apex): PA > Pa > Pv → theoretical dead space (normally absent)
  Zone 2 (middle): Pa > PA > Pv → flow intermittent
  Zone 3 (base): Pa > Pv > PA → flow continuous

Mnemonic for West's Zones: "A-a-v, a-A-v, a-v-A" (Alveolar, arterial, venous pressures in order of Zone 1, 2, 3)

---

7. THE SHUNT EQUATION

QS/QT = (CcO2 - CaO2) / (CcO2 - CvO2)

Where:
  QS/QT = fraction of cardiac output that is shunted
  CcO2  = end-capillary O2 content (ideal)
  CaO2  = arterial O2 content (measured)
  CvO2  = mixed venous O2 content (measured in PA)

Normal physiological shunt: <5% (bronchial veins, thebesian veins drain into left side)
Pathological shunt: >5%
Severe shunt: >20% → refractory hypoxemia

---

8. DIAGNOSING HYPOXEMIA - A CLINICAL ALGORITHM

Patient has HYPOXEMIA (PaO2 < 60 mmHg)
              ↓
STEP 1: Calculate A-a gradient (PAO2 - PaO2)
              ↓
         ┌────────────────┬───────────────────┐
    NORMAL A-a (<15)      ELEVATED A-a (>15)
              ↓                     ↓
    Check PaCO2:         STEP 2: Give 100% O2
              ↓                     ↓
    If ↑ PaCO2:          ┌──────────────────┐
    → HYPOVENTILATION    Corrects?  Not Corrects?
    (opioids, CNS)           ↓           ↓
    If normal PaCO2:    V/Q or    TRUE SHUNT
    → Low FiO2          Diffusion  (ARDS, intracardiac)
    (altitude)          Defect

---

9. THE RESPONSE TO SUPPLEMENTAL O2

---

10. MEMORY ANCHORS - DAY 5

• Normal = lung is blameless, problem is upstream (ventilation drive, inspired air)
• Elevated = lung itself is the problem

• Zone 1: Alveolar > arterial
• Zone 2: Arterial > Alveolar
• Zone 3: Arterial > venous (normal physiology)

---

11. EXAM PEARLS - DAY 5

• Normal A-a gradient < 15 mmHg (increases with age and on supplemental O2)
• Shunt = V/Q 0 = does not improve with 100% FiO2 - classic USMLE question
• TB prefers lung apex because high V/Q → high PO2 → ideal for aerobic mycobacteria
• Base of lung = most ventilation AND most perfusion (but perfusion greater → lower V/Q)
• Hypoventilation raises PaCO2 and displaces O2 from alveolus (PAO2 falls even though A-a gradient is normal)
• PA catheter (Swan-Ganz) measures mixed venous PO2 - needed for shunt fraction calculation

---

---

DAY 6

WEEKLY MASTER REVIEW, ACTIVE RECALL & CLINICAL SCENARIO SIMULATION

---

RAPID INTEGRATION MAP - WEEK 1

EMBRYOLOGY (Day 1)
    ↓
The lung starts as a foregut bud
    ↓
5 stages: Embryonic → Pseudoglandular → Canalicular → Saccular → Alveolar
    ↓
Separation failure = TEF (Type C, 88%)
    ↓
ARCHITECTURE (Day 2)
    ↓
Conducting zone (Gen 0-16) = dead space = mucus + cilia system
    ↓
Respiratory zone (Gen 17-23) = gas exchange
    ↓
Type II cells → surfactant → alveolar stability
    ↓
MECHANICS (Day 3)
    ↓
Pleural pressure (-5 cmH2O) holds lung open
    ↓
Compliance = ΔV/ΔP (emphysema=high; fibrosis=low)
    ↓
Surfactant → reduces surface tension → LaPlace stability
    ↓
SPIROMETRY (Day 4)
    ↓
FEV1/FVC < 0.70 = obstruction (scooped loop)
    ↓
FVC reduced + normal ratio = restriction (narrow loop)
    ↓
DLCO: down in emphysema & fibrosis, normal in bronchitis & asthma
    ↓
GAS EXCHANGE (Day 5)
    ↓
Alveolar gas equation → A-a gradient
    ↓
5 causes of hypoxemia → shunt is the only one unresponsive to O2
    ↓
V/Q = 0 (shunt) ↔ V/Q = ∞ (dead space) ↔ normal = 0.8

---

ACTIVE RECALL - 25 MUST-ANSWER QUESTIONS

Embryology

1. At what gestational week does the respiratory diverticulum first appear?
2. Which embryological stage marks the viability threshold (~24 weeks) and why?
3. Type C TEF: which end of the esophagus connects to the trachea? What is the clinical consequence?
4. Why does Type A EA produce a gasless abdomen on X-ray while Type C produces air in the stomach?
5. Name the 5 components of VACTERL.
6. What mutation causes Kartagener's syndrome, and what are the three clinical features?

Histology

1. What type of epithelium lines the trachea and main bronchi?
2. Where do goblet cells END in the airway (i.e., below which generation are they replaced)?
3. What cell type replaces goblet cells in the bronchioles?
4. Which cell is the stem cell of the alveolar epithelium?
5. What are "heart failure cells" and why do they have their name?
6. What is the function of pores of Kohn?

Mechanics

1. What is the intrapleural pressure at FRC?
2. Define compliance. Give the unit. Which is higher: emphysema or fibrosis?
3. Write the LaPlace equation. Why does surfactant stabilize alveoli of different sizes?
4. Name the 4 surfactant proteins. Which two are responsible for surface activity?
5. Which lung volumes CANNOT be measured by spirometry alone?
6. What is the clinical value of betamethasone given to a mother at 30 weeks gestation?

Spirometry

1. What FEV1/FVC ratio defines airflow obstruction?
2. What shape does the expiratory limb of the flow-volume loop take in obstruction?
3. What is the DLCO in asthma? In emphysema?
4. What distinguishes "reversible" from "irreversible" obstruction in spirometry?
5. A patient has a "fixed plateau" on BOTH inspiratory and expiratory limbs. Diagnosis?

Gas Exchange

1. Calculate the PAO2 at sea level, room air, with PaCO2 = 40 mmHg (assume RQ = 0.8).
2. A patient on 100% FiO2 still has PaO2 = 55 mmHg. What is the mechanism? Name one clinical cause.

---

1. Week 4
2. Canalicular (respiratory bronchioles + alveolar-capillary interface develop); below this, no surface for gas exchange
3. DISTAL pouch connects to trachea; air enters stomach → distension; gastric acid enters trachea → chemical pneumonitis
4. Type A: no fistula at all; no air pathway to stomach. Type C: distal fistula; air passes down to stomach
5. Vertebral, Anal atresia, Cardiac, TracheoEsophageal fistula, Renal, Limb
6. Dynein arm defect (DNAI1/DNAH5); bronchiectasis + situs inversus + male infertility
7. Pseudostratified ciliated columnar epithelium
8. Goblet cells end at the level of the bronchi - absent from bronchioles
9. Club (Clara) cells
10. Type II pneumocyte
11. Alveolar macrophages laden with hemosiderin (from phagocytosed RBCs in pulmonary edema/LHF); stain blue with Prussian blue
12. Collateral ventilation between alveoli - prevents collapse of alveoli served by blocked airways
13. -5 cm H2O
14. ΔV/ΔP (mL/cmH2O); Emphysema is higher compliance
15. P = 2T/r; surfactant decreases T as alveolus shrinks → prevents small alveoli from collapsing into large ones
16. SP-A, SP-B, SP-C, SP-D; SP-B and SP-C are surface-active
17. RV, FRC, TLC (anything containing RV)
18. Induces Type II cell maturation → surfactant production → reduces risk of RDS in premature infant
19. < 0.70
20. Scooped (concave) - classic "scooped out" appearance
21. Asthma: normal DLCO; Emphysema: reduced DLCO
22. ≥12% AND ≥200 mL improvement in FEV1 = reversible (asthma); less = irreversible (COPD)
23. Fixed upper airway obstruction (tracheal stenosis, goitre, post-intubation stricture)
24. PAO2 = 0.21 × (760-47) - 40/0.8 = 149.7 - 50 = ~100 mmHg
25. True (right-to-left) shunt - blood bypasses alveoli; examples: ARDS, intracardiac shunt (ASD/VSD), hepatopulmonary syndrome

---

CLINICAL SCENARIO SIMULATIONS

Scenario 1 - Neonatal Emergency

• Diagnosis: TEF Type C (most common)
• Immediate actions: Stop oral feeding; nurse head-up; Replogle suction of upper pouch; IV access; blood sugar
• Investigations: CXR (confirm NGT coiling; gas in abdomen); ECHO (cardiac defect)
• Treatment: Surgical ligation of fistula + esophageal anastomosis
• What will the CXR show? NGT coiled in upper mediastinum/chest + GAS visible in stomach

---

Scenario 2 - Spirometry Interpretation

• Pattern: Obstructive (ratio 0.40 < 0.70)
• GOLD stage: 3 (Severe) - FEV1 45%
• DLCO reduced → suggests emphysematous component (not pure chronic bronchitis)
• Post-bronchodilator improvement: 0.1L = 8.3% (< 12%) = irreversible → COPD confirmed
• Diagnosis: COPD with emphysematous component

---

Scenario 3 - Hypoxemia Analysis

• A-a gradient: PAO2 on 100% O2 ≈ 663 mmHg. A-a = 663 - 55 = 608 (massively elevated)
• Shunt: PaO2 does NOT correct with 100% O2
• P/F ratio: 55/1.0 = 55 (severe ARDS < 100)
• Diagnosis: ARDS (diffuse alveolar damage with shunt physiology)
• Treatment: Prone positioning, lung-protective ventilation, PEEP to recruit alveoli

---

WEEK 1 - FINAL ONE-PAGE ULTRA HIGH-YIELD SUMMARY

╔══════════════════════════════════════════════════════════════════════╗
║           WEEK 1 RESPIRATORY MEDICINE - MASTER SUMMARY              ║
╠══════════════════════════════════════════════════════════════════════╣
║ EMBRYOLOGY                                                           ║
║ • 5 stages: E-P-C-S-A (Embryonic-Pseudo-Canalicular-Saccular-Alv)  ║
║ • TEF: Type C (88%) = blind upper pouch + distal fistula            ║
║ • VACTERL: always check heart, kidneys, spine, anus                 ║
║ • Viability threshold: ~24 weeks (Canalicular stage)                ║
╠══════════════════════════════════════════════════════════════════════╣
║ HISTOLOGY                                                            ║
║ • Conducting zone (Gen 0-16) = dead space = 150 mL                  ║
║ • Goblet cells → bronchi only; Club cells → bronchioles              ║
║ • Type I: gas exchange (95% area); Type II: surfactant + stem cell  ║
║ • Mucociliary escalator: broken by smoking, CF, Kartagener's        ║
╠══════════════════════════════════════════════════════════════════════╣
║ MECHANICS                                                            ║
║ • Ppl = -5 cmH2O at FRC; inspiration makes it more negative         ║
║ • Compliance = ΔV/ΔP; HIGH in emphysema, LOW in fibrosis            ║
║ • Surfactant: DPPC by Type II cells; reduces T as alveolus shrinks  ║
║ • LaPlace: P = 2T/r; surfactant prevents small-into-big collapse    ║
║ • FRC, RV, TLC need plethysmography (NOT on spirometry alone)       ║
╠══════════════════════════════════════════════════════════════════════╣
║ SPIROMETRY                                                           ║
║ • FEV1/FVC < 0.70 = OBSTRUCTION                                     ║
║ • FVC reduced + normal ratio = RESTRICTION (confirm TLC by body box)║
║ • Scooped expiratory limb = airway obstruction                      ║
║ • DLCO low in emphysema + fibrosis; NORMAL in bronchitis + asthma   ║
║ • ≥12% + ≥200 mL FEV1 rise = reversible (asthma)                   ║
╠══════════════════════════════════════════════════════════════════════╣
║ GAS EXCHANGE                                                         ║
║ • PAO2 = FiO2 × (760-47) - PaCO2/0.8 → ~100 mmHg at room air       ║
║ • A-a gradient normal → hypoventilation or low FiO2                 ║
║ • A-a elevated → V/Q mismatch, diffusion defect, or shunt           ║
║ • SHUNT: only cause NOT corrected by 100% O2                        ║
║ • V/Q = 0 (shunt) | V/Q = 0.8 (normal) | V/Q = ∞ (dead space)     ║
║ • Apex: high V/Q, high PO2 → TB loves it here                       ║
║ • Base: low V/Q, low PO2 → edema + pneumonia pool here              ║
╠══════════════════════════════════════════════════════════════════════╣
║ TOP 5 MUST-KNOW FOR EXAMS                                            ║
║ 1. TEF Type C = 88% → distal fistula → gas in stomach on AXR        ║
║ 2. FEV1/FVC < 0.70 = obstruction (Tiffeneau index)                  ║
║ 3. Surfactant: LaPlace law: lowers T as r decreases                  ║
║ 4. Shunt = refractory hypoxemia (NO response to 100% O2)            ║
║ 5. Type II pneumocytes = surfactant factories + alveolar stem cells  ║
╚══════════════════════════════════════════════════════════════════════╝

---

---

What Was Covered - Week 1 Complete